High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
NCT04331639
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The investigators will be administering oral high dose interval vitamin D, concurrently when participants are receiving biologic therapy for their inflammatory bowel disease. The investigators will be collecting some additional bloodwork and questionnaires at the time of participants infusions.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Inflammatory Bowel Disease
- Crohn Disease
- Ulcerative Colitis
- Vitamin D Deficiency
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 5 to 25 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Boston Children's Hospital
- Last updated on ClinicalTrials.gov
- March 3, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Boston Children's Hospital · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.